Study to Evaluate is ECV Success is Improved and the Side Effects Reduced With the Use of IV NTGL Versus Terbutaline

Condition:   External Cephalic Version
Interventions:   Drug: Intravenous Terbutaline;   Drug: Intravenous Nitroglycerine
Sponsors:   Mount Sinai School of Medicine;   Yaakov Beilin
Not yet recruiting – verified April 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days